Psyence Biomedical Ltd.
PBM
$1.77
$0.1912.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.67M | 3.41M | 3.37M | 3.11M | 2.85M |
| Depreciation & Amortization | 5.00K | 4.70K | 4.30K | 3.20K | 2.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.45M | 4.10M | 3.85M | 3.63M | 3.41M |
| Operating Income | -4.45M | -4.10M | -3.85M | -3.63M | -3.41M |
| Income Before Tax | -3.70M | -2.80M | -327.00K | -24.13M | -47.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.70 | -2.80 | -0.33 | -24.13 | -47.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.70M | -2.80M | -327.00K | -24.13M | -47.93M |
| EBIT | -4.45M | -4.10M | -3.85M | -3.63M | -3.41M |
| EBITDA | -4.44M | -4.09M | -3.85M | -3.63M | -3.41M |
| EPS Basic | -6.91 | -2.32 | 49.76 | -1.05K | -2.16K |
| Normalized Basic EPS | -4.14 | -29.51 | -44.73 | -52.06 | -59.40 |
| EPS Diluted | -6.91 | -2.33 | 49.74 | -1.05K | -2.16K |
| Normalized Diluted EPS | -4.14 | -29.50 | -44.72 | -52.05 | -59.39 |
| Average Basic Shares Outstanding | 3.26M | 1.81M | 777.80K | 443.10K | 108.40K |
| Average Diluted Shares Outstanding | 3.26M | 1.81M | 777.90K | 443.20K | 108.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |